These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15572713)

  • 1. Vitamin K deficiency and hepatocellular carcinoma.
    Piquet MA; Hourmand-Ollivier I; Dao T
    JAMA; 2004 Dec; 292(21):2580-1; author reply 2581. PubMed ID: 15572713
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.
    Habu D; Shiomi S; Tamori A; Takeda T; Tanaka T; Kubo S; Nishiguchi S
    JAMA; 2004 Jul; 292(3):358-61. PubMed ID: 15265851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitamin K2 on the development of hepatocellular carcinoma in type C cirrhosis.
    Kojima K; Tamano M; Akima T; Hashimoto T; Kuniyoshi T; Maeda C; Majima Y; Kusano K; Murohisa T; Iijima M; Hiraishi H
    Hepatogastroenterology; 2010; 57(102-103):1264-7. PubMed ID: 21410069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening of hepatocellular carcinoma in patients with liver cirrhosis].
    Pateron D; Ganne N; Beaugrand M
    Ann Chir; 1993; 47(3):203-5. PubMed ID: 7687419
    [No Abstract]   [Full Text] [Related]  

  • 5. [What is the value of systematic screening of hepatocellular carcinomas in patients with liver cirrhosis?].
    Pateron D
    Gastroenterol Clin Biol; 1992; 16(11):908-9. PubMed ID: 1336468
    [No Abstract]   [Full Text] [Related]  

  • 6. Pleiotropic actions of vitamin K: protector of bone health and beyond?
    Kaneki M; Hosoi T; Ouchi Y; Orimo H
    Nutrition; 2006; 22(7-8):845-52. PubMed ID: 16815498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of hepatocellular carcinogenesis by interferon].
    Ikeda K
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():755-63. PubMed ID: 11762051
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sho-saiko-to].
    Oka H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():774-8. PubMed ID: 11762055
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma.
    Hessheimer AJ; Forner A; Varela M; Bruix J
    Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1239-44. PubMed ID: 20505515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coffee, liver enzymes, cirrhosis and liver cancer.
    La Vecchia C
    J Hepatol; 2005 Apr; 42(4):444-6. PubMed ID: 15763323
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening of hepatocellular carcinoma in French patients.
    Durand F; Buffet C; Pelletier G; Hagege H; Ink O; Etienne JP
    Dig Dis Sci; 1995 Mar; 40(3):706-7. PubMed ID: 7895568
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge.
    Poon RT
    Hepatology; 2011 Sep; 54(3):757-9. PubMed ID: 21793027
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.
    Zhong YD; Yang YF
    Hepatology; 2008 Oct; 48(4):1348; author reply 1348. PubMed ID: 18792394
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.
    Chen TH; Chiu SY
    Hepatology; 2008 Oct; 48(4):1348-9. PubMed ID: 18792397
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitamin D and K signaling pathways in hepatocellular carcinoma.
    Louka ML; Fawzy AM; Naiem AM; Elseknedy MF; Abdelhalim AE; Abdelghany MA
    Gene; 2017 Sep; 629():108-116. PubMed ID: 28764978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
    Yoshida H; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].
    Nishiguchi S; Kubo S; Shiomi S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):600-4. PubMed ID: 15359868
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epidemiology, prevention, screening and diagnosis of hepatocellular carcinoma].
    Trinchet JC; Alperovitch A; Bedossa P; Degos F; Hainaut P; Beers BV
    Bull Cancer; 2009 Jan; 96(1):35-43. PubMed ID: 19211358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatocellular carcinoma and vitamin K2].
    Mizuta T; Ozaki I
    Clin Calcium; 2015 Nov; 25(11):1645-51. PubMed ID: 26503869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of vitamin K for hepatocellular carcinoma].
    Mizuta T; Ozaki I
    Clin Calcium; 2007 Nov; 17(11):1693-9. PubMed ID: 17982189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.